{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T23:16:58Z","timestamp":1793575018701,"version":"4.5.0"},"reference-count":21,"publisher":"The Journal of Rheumatology","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,8,25]]},"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We assessed changes in health-related quality of life (HRQOL) in Canadian patients with juvenile idiopathic arthritis (JIA), comparing inception cohorts from 2017 to 2023 and 2005 to 2010.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We included newly diagnosed patients who completed the Juvenile Arthritis Quality of Life Questionnaire (JAQQ) at both enrollment and 1 year later. Mean changes in JAQQ domain scores from baseline to 1 year were compared between cohorts using Mann-Whitney\n                      <jats:italic>U<\/jats:italic>\n                      tests. Multivariable linear regression was used to adjust for baseline imbalances between the cohorts. We also compared changes in treatments, the Quality of My Life scale, arthritis pain, Childhood Health Assessment Questionnaire disability index, and physician and parent global assessments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We included 478 and 663 patients from the 2017-2023 and 2005-2010 cohorts, respectively. By 1 year, a greater proportion of patients in the 2017-2023 cohort had used conventional synthetic and biologic disease-modifying antirheumatic drugs compared to the 2005-2010 cohort (57.9% vs 46.2% and 27.2% vs 6.3%, respectively). Improvements in total JAQQ score from baseline to 1 year were similar between the 2017-2023 (0.97; 95% CI 0.85-1.09) and 2005-2010 (0.92; 95% CI 0.82-1.02) cohorts, with no significant difference observed across JAQQ domains. Pain scores, however, improved significantly (\u22122.07 vs \u22121.62,\n                      <jats:italic>P<\/jats:italic>\n                      = 0.03). After adjusting for baseline imbalances, greater improvements were observed in the 2017-2023 cohort for all JAQQ domains in patients with \u2265 5 active joints (\u03b2 0.28 for psychosocial to \u03b2 0.62 for gross motor).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>First-year improvements in HRQOL measured by JAQQ were similar in the 2017-2023 and 2005-2010 cohorts, but adjustment for baseline imbalances suggests greater HRQOL improvements in those with more severe disease in the later cohort.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-0377","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T12:25:22Z","timestamp":1757939122000},"page":"186-193","source":"Crossref","is-referenced-by-count":3,"title":["Effect of Treatment Changes on Health-Related Quality of Life in Canadian Children With Juvenile Idiopathic Arthritis: Results From ReACCh-Out and CAPRI"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4664-0025","authenticated-orcid":false,"given":"Zoe","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6616-1689","authenticated-orcid":false,"given":"Adam M.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiem","family":"Oen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0972-3502","authenticated-orcid":false,"given":"Jean-Philippe","family":"Proulx-Gauthier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9702-7776","authenticated-orcid":false,"given":"Ga\u00eblle","family":"Ch\u00e9deville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2481-5821","authenticated-orcid":false,"given":"Gilles","family":"Boire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-4640","authenticated-orcid":false,"given":"Dax G.","family":"Rumsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7174-1007","authenticated-orcid":false,"given":"Kristin M.","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6412-1029","authenticated-orcid":false,"given":"Michelle","family":"Batthish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2780-0617","authenticated-orcid":false,"given":"Roberta A.","family":"Berard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8142-8946","authenticated-orcid":false,"given":"Heinrike","family":"Schmeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5372-2950","authenticated-orcid":false,"given":"Y. Ingrid","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciaran","family":"Duffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8977-2581","authenticated-orcid":false,"given":"Jaime","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"for the ReACCh-Out and CAPRI Registry Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"key":"2026070105051074000_53.2.186.1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23236"},{"key":"2026070105051074000_53.2.186.2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13075-018-1588-x","article-title":"The majority of patients with newly diagnosed juvenile idiopathic arthritis achieve a health-related quality of life that is similar to that of healthy peers: results of the German multicenter inception cohort (ICON)","volume":"20","author":"Listing","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2026070105051074000_53.2.186.3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41572-021-00332-8","article-title":"Juvenile idiopathic arthritis","volume":"8","author":"Martini","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"2026070105051074000_53.2.186.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213030"},{"key":"2026070105051074000_53.2.186.5","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2014.212"},{"key":"2026070105051074000_53.2.186.6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12969-020-00428-7","article-title":"Treating juvenile idiopathic arthritis to target: what is the optimal target definition to reach all goals?","volume":"18","author":"Schoemaker","year":"2020","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026070105051074000_53.2.186.7","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1093\/rheumatology\/keab079","article-title":"Causal pathways to health-related quality of life in children with juvenile idiopathic arthritis: results from the ReACCh-Out cohort","volume":"60","author":"Oen","year":"2021","journal-title":"Rheumatology"},{"key":"2026070105051074000_53.2.186.8","doi-asserted-by":"crossref","first-page":"SI173","DOI":"10.1093\/rheumatology\/kead560","article-title":"A decade of progress in juvenile idiopathic arthritis treatments and outcomes in Canada: results from ReACCh-Out and the Capri registry","volume":"63","author":"Nguyen","year":"2024","journal-title":"Rheumatology"},{"key":"2026070105051074000_53.2.186.9","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205372"},{"key":"2026070105051074000_53.2.186.10","first-page":"390","article-title":"International League of Associations for Rheumatology classification of juvenile idiopathic arthritis, second revision, Edmonton, 2001","volume":"31","author":"Petty","year":"2004","journal-title":"J Rheumatol"},{"key":"2026070105051074000_53.2.186.11","first-page":"738","article-title":"The Juvenile Arthritis Quality of Life Questionnaire\u2014development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides","volume":"24","author":"Duffy","year":"1997","journal-title":"J Rheumatol"},{"key":"2026070105051074000_53.2.186.12","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780371209"},{"key":"2026070105051074000_53.2.186.13","first-page":"226","article-title":"Distinction of quality of life, health related quality of life, and health status in children referred for rheumatologic care","volume":"27","author":"Feldman","year":"2000","journal-title":"J Rheumatol"},{"key":"2026070105051074000_53.2.186.14","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1186\/s13075-020-02326-5","article-title":"Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry","volume":"22","author":"Armaroli","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"2026070105051074000_53.2.186.15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/acr.23709","article-title":"Time of disease-modifying antirheumatic drug start in juvenile idiopathic arthritis and the likelihood of a drug-free remission in young adulthood","volume":"71","author":"Minden","year":"2019","journal-title":"Arthritis Care Res"},{"key":"2026070105051074000_53.2.186.16","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/rheumatology\/keac312","article-title":"Is time a healer? How quality of life changes over time reported by parents of children and young people with juvenile idiopathic arthritis","volume":"62","author":"Smith","year":"2023","journal-title":"Rheumatology"},{"key":"2026070105051074000_53.2.186.17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/acr.22112","article-title":"Improvement in health-related quality of life for children with juvenile idiopathic arthritis after start of treatment with etanercept","volume":"66","author":"Klotsche","year":"2014","journal-title":"Arthritis Care Res"},{"key":"2026070105051074000_53.2.186.18","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.3389\/fpsyg.2019.02445","article-title":"Child and family adaptation to juvenile idiopathic arthritis-a systematic review of the role of resilience resources and mechanisms","volume":"10","author":"Hynes","year":"2019","journal-title":"Front Psychol"},{"key":"2026070105051074000_53.2.186.19","doi-asserted-by":"publisher","DOI":"10.2147\/OARRR.S174408"},{"key":"2026070105051074000_53.2.186.20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12969-022-00713-7","article-title":"Factors associated with care- and health-related quality of life of caregivers of children with juvenile idiopathic arthritis","volume":"20","author":"Grazziotin","year":"2022","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026070105051074000_53.2.186.21","doi-asserted-by":"crossref","first-page":"13913","DOI":"10.3390\/ijms232213913","article-title":"Therapeutic utility and adverse effects of biologic disease-modifying anti-rheumatic drugs in inflammatory arthritis","volume":"23","author":"Min","year":"2022","journal-title":"Int J Mol Sci"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0377","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T12:13:28Z","timestamp":1782908008000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":21,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2,1]]},"published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10.3899\/jrheum.2025-0377"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0377","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]}}}